Financhill
Buy
66

PRLB Quote, Financials, Valuation and Earnings

Last price:
$39.10
Seasonality move :
9.23%
Day range:
$37.49 - $39.65
52-week range:
$25.76 - $46.73
Dividend yield:
0%
P/E ratio:
65.07x
P/S ratio:
1.95x
P/B ratio:
1.41x
Volume:
224.8K
Avg. volume:
224.9K
1-year change:
25.57%
Market cap:
$928M
Revenue:
$500.9M
EPS (TTM):
$0.60

Earnings Data

Next earnings date for PRLB
Aug 01
2025
Most recent earnings per share
$0.15
Missed by $0.14
(May 2/2025)
Consensus Estimate
$0.29
(May 2/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PRLB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/01/2025 Q2 $128.1M -- -- $0.34 --
05/02/2025 Q1 $123.7M $126.2M $0.15 $0.29 -$0.14
02/07/2025 Q4 $120.1M $121.8M -$0.02 $0.32 -$0.34
11/01/2024 Q3 $121.4M $125.6M $0.29 $0.32 -$0.03
08/02/2024 Q2 $126.2M $125.6M $0.18 $0.35 -$0.17
05/03/2024 Q1 $124.7M $127.9M $0.20 $0.31 -$0.11
02/09/2024 Q4 $122.7M $125M $0.27 $0.31 -$0.04
11/03/2023 Q3 -- -- $0.31 $0.30 $0.01
08/04/2023 Q2 -- -- -$0.01 $0.30 -$0.31
05/05/2023 Q1 -- -- $0.10 $0.23 -$0.13
02/10/2023 Q4 -- -- -$4.24 $0.21 -$4.45
11/04/2022 Q3 -- -- $0.14 $0.40 -$0.26
08/05/2022 Q2 -- -- $0.09 $0.39 -$0.30
05/06/2022 Q1 -- -- $0.19 $0.28 -$0.09
02/11/2022 Q4 -- -- $0.43 $0.27 $0.16
10/28/2021 Q3 -- -- $0.17 $0.43 -$0.26
07/29/2021 Q2 -- -- $0.47 $0.44 $0.03
05/06/2021 Q1 -- -- $0.13 $0.40 -$0.27
02/12/2021 Q4 -- -- $0.36 $0.49 -$0.13
10/29/2020 Q3 -- -- $0.55 $0.52 $0.03
07/28/2020 Q2 -- -- $0.47 $0.41 $0.07
04/30/2020 Q1 -- -- $0.52 $0.45 $0.07
02/06/2020 Q4 -- -- $0.56 $0.63 -$0.07
10/24/2019 Q3 -- -- $0.62 $0.74 -$0.12
07/25/2019 Q2 -- -- $0.71 $0.70 $0.01
04/25/2019 Q1 -- -- $0.69 $0.69 -$0.00
02/07/2019 Q4 -- -- $0.74 $0.80 -$0.06
10/25/2018 Q3 -- -- $0.86 $0.74 $0.12
07/26/2018 Q2 -- -- $0.73 $0.72 $0.01
04/26/2018 Q1 -- -- $0.71 $0.68 $0.03
02/08/2018 Q4 -- -- $0.58 $0.56 $0.02
10/26/2017 Q3 -- -- $0.56 $0.52 $0.04
07/27/2017 Q2 -- -- $0.49 $0.48 $0.01
04/27/2017 Q1 -- -- -- $0.40 --
02/09/2017 Q4 -- -- $0.35 $0.35 --
10/27/2016 Q3 -- -- $0.45 $0.39 $0.06
07/28/2016 Q2 -- -- $0.41 $0.45 -$0.04
04/28/2016 Q1 -- -- $0.40 $0.42 -$0.02
02/04/2016 Q4 -- -- $0.45 $0.43 $0.02
10/22/2015 Q3 -- -- $0.48 $0.49 -$0.01
07/23/2015 Q2 -- -- $0.46 $0.44 $0.02

Proto Labs Earnings Questions

  • How Much did Proto Labs Generate in Revenue Last Quarter?

    Proto Labs reported $126.2M worth of top line sales in its most recent quarter.

  • Did Proto Labs Beat Earnings Last Quarter?

    Proto Labs announced earnings per share of $0.15 which represents a miss of analyst forecast a $0.29 per share.

  • Is Proto Labs Profitable?

    Proto Labs reported $55.7M that represents $2.28 per share over the last quarter.

  • What is the Analyst Consensus for Proto Labs EPS Next Year?

    Proto Labs's earnings are forecast to grow from $0.66 per share to $1.57 per share next year representing an increase of 107.58%.

  • When is Proto Labs's Earnings Date?

    Proto Labs's next earnings date is August 1, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock